View Item 

Show simple item record

Inpatient inherited thrombophilia testing
dc.contributor.authorPetrilli, Christopher M.
dc.contributor.authorHeidemann, Lauren
dc.contributor.authorMack, Megan
dc.contributor.authorDurance, Paul
dc.contributor.authorChopra, Vineet
dc.date.accessioned2016-11-18T21:24:04Z
dc.date.available2018-01-08T19:47:53Zen
dc.date.issued2016-11
dc.identifier.citationPetrilli, Christopher M.; Heidemann, Lauren; Mack, Megan; Durance, Paul; Chopra, Vineet (2016). "Inpatient inherited thrombophilia testing." Journal of Hospital Medicine 11(11): 801-804.
dc.identifier.issn1553-5592
dc.identifier.issn1553-5606
dc.identifier.urihttps://hdl.handle.net/2027.42/134469
dc.publisherWiley Periodicals, Inc.
dc.titleInpatient inherited thrombophilia testing
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/1/jhm2616-sup-0003-suppinfo3.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/2/jhm2616.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/3/jhm2616-sup-0004-suppinfo4.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/4/jhm2616-sup-0001-suppinfo1.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/5/jhm2616-sup-0006-suppinfo6.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/6/jhm2616-sup-0005-suppinfo5.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/7/jhm2616-sup-0002-suppinfo2.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134469/8/jhm2616_am.pdf
dc.identifier.doi10.1002/jhm.2616
dc.identifier.sourceJournal of Hospital Medicine
dc.identifier.citedreferenceAbramson N, Abramson S. Hypercoagulability: clinical assessment and treatment. South Med J. 2001; 94 ( 10 ): 1013 – 1020.
dc.identifier.citedreferenceHo WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med. 2006; 166 ( 7 ): 729 – 736.
dc.identifier.citedreferenceVigano D’Angelo S, Comp PC, Esmon CT, D’Angelo A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest. 1986; 77 ( 2 ): 416 – 425.
dc.identifier.citedreferencePatnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia. 2008; 14 ( 6 ): 1229 – 1239.
dc.identifier.citedreferenceWeiss P, Soff GA, Halkin H, Seligsohn U. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res. 1987; 45 ( 6 ): 783 – 790.
dc.identifier.citedreferenceHeit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program. 2007: 127 – 135.
dc.identifier.citedreferenceKadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. Am J Hematol. 2014; 89 ( 12 ): 1147 – 1150.
dc.identifier.citedreferenceFair DS, Revak DJ. Quantitation of human protein S in the plasma of normal and warfarin‐treated individuals by radioimmunoassay. Thromb Res. 1984; 36 ( 6 ): 527 – 535.
dc.identifier.citedreferenceBank I, Scavenius MP, Buller HR, Middeldorp S. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res. 2004; 113 ( 1 ): 7 – 12.
dc.identifier.citedreferenceSomma J, Sussman, II, Rand JH. An evaluation of thrombophilia screening in an urban tertiary care medical center: A “real world” experience. Am J Clin Pathol. 2006; 126 ( 1 ): 120 – 127.
dc.identifier.citedreferenceCodeMap. Available at: https://www.codemap.com. Accessed January 18, 2016.
dc.identifier.citedreferenceEvaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med. 2011; 13 ( 1 ): 67 – 76.
dc.identifier.citedreferenceBrill‐Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000; 343 ( 20 ): 1439 – 1444.
dc.identifier.citedreferenceFriederich PW, Sanson BJ, Simioni P, et al. Frequency of pregnancy‐related venous thromboembolism in anticoagulant factor‐deficient women: implications for prophylaxis. Ann Intern Med. 1996; 125 ( 12 ): 955 – 960.
dc.identifier.citedreferenceChong LY, Fenu E, Stansby G, Hodgkinson S; Guideline Development Group. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ. 2012; 344: e3979.
dc.identifier.citedreferenceAmerican Society of Hematology. Ten things physicians and patients should question. Choosing Wisely website. Available at: http://www.choosingwisely.org/societies/american‐society‐of‐hematology. Published December 4, 2013. Accessed January 18, 2016.
dc.identifier.citedreferenceAmerican College of Medical Genetics and Genomics. Five Things patients and providers should question. Choosing Wisely website. Available at: http://www.choosingwisely.org/societies/american‐college‐of‐medical‐genetics‐and‐genomics. Published July 10, 2015. Accessed March 13, 2016.
dc.identifier.citedreferenceSilverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25‐year population‐based study. Arch Intern Med. 1998; 158 ( 6 ): 585 – 593.
dc.identifier.citedreferenceCarson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992; 326 ( 19 ): 1240 – 1245.
dc.identifier.citedreferenceKhan S, Dickerman JD. Hereditary thrombophilia. Thromb J. 2006; 4: 15.
dc.identifier.citedreferenceLensing AW, Prandoni P, Prins MH, Buller HR. Deep‐vein thrombosis. Lancet. 1999; 353 ( 9151 ): 479 – 485.
dc.identifier.citedreferenceBarbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010; 8 ( 11 ): 2450 – 2457.
dc.identifier.citedreferenceBates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest. 2012; 141 ( 2 suppl ): e691S – e736S.
dc.identifier.citedreferenceDe Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost. 2013; 110 ( 4 ): 697 – 705.
dc.identifier.citedreferenceKahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest. 2012; 141 ( 2 suppl ): e195S – e226S.
dc.identifier.citedreferenceSegal JB, Brotman DJ, Necochea AJ, et al. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA. 2009; 301 ( 23 ): 2472 – 2485.
dc.identifier.citedreferenceCohn D, Vansenne F, de Borgie C, Middeldorp S. Thrombophilia testing for prevention of recurrent venous thromboembolism. Cochrane Database Syst Rev. 2009;( 1 ): CD007069.
dc.identifier.citedreferenceCohn DM, Vansenne F, de Borgie CA, Middeldorp S. Thrombophilia testing for prevention of recurrent venous thromboembolism. Cochrane Database Syst Rev. 2012; 12: CD007069.
dc.identifier.citedreferenceBaglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003; 362 ( 9383 ): 523 – 526.
dc.identifier.citedreferenceKearon C, Julian JA, Kovacs MJ, et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 2008; 112 ( 12 ): 4432 – 4436.
dc.identifier.citedreferenceMerriman L, Greaves M. Testing for thrombophilia: an evidence‐based approach. Postgrad Med J. 2006; 82 ( 973 ): 699 – 704.
dc.identifier.citedreferenceChristiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005; 293 ( 19 ): 2352 – 2361.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jhm2616-sup-0003-suppinfo3.pdf
Size:
510.2KB
Format:
PDF
View/Open
Name:
jhm2616.pdf
Size:
117.2KB
Format:
PDF
View/Open
Name:
jhm2616-sup-0004-suppinfo4.pdf
Size:
510.1KB
Format:
PDF
View/Open
Name:
jhm2616-sup-0001-suppinfo1.pdf
Size:
358.4KB
Format:
PDF
View/Open
Name:
jhm2616-sup-0006-suppinfo6.pdf
Size:
510.1KB
Format:
PDF
View/Open
Name:
jhm2616-sup-0005-suppinfo5.pdf
Size:
510.2KB
Format:
PDF
View/Open
Name:
jhm2616-sup-0002-suppinfo2.pdf
Size:
510.2KB
Format:
PDF
View/Open
Name:
jhm2616_am.pdf
Size:
198.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.